Publikationen in Zusammenarbeit mit Forschern von Maastricht University (22)

2012

  1. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe

    European Journal of Cancer, Vol. 48, Núm. 2, pp. 159-169

  2. Coffee and tea consumption and the risk of ovarian cancer: A prospective cohort study and updated meta-analysis

    American Journal of Clinical Nutrition, Vol. 95, Núm. 5, pp. 1172-1181

  3. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe

    European Journal of Cancer, Vol. 48, Núm. 8, pp. 1167-1175

  4. Epidemiology of glial and non-glial brain tumours in Europe

    European Journal of Cancer, Vol. 48, Núm. 10, pp. 1532-1542

  5. Incidence and survival of rare urogenital cancers in Europe

    European Journal of Cancer, Vol. 48, Núm. 4, pp. 456-464

  6. Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002

    European Journal of Cancer, Vol. 48, Núm. 10, pp. 1417-1424

2011

  1. Fetal umbilical artery Doppler to predict compromise of fetal/neonatal wellbeing in a high-risk population: Systematic review and bivariate meta-analysis

    Ultrasound in Obstetrics and Gynecology, Vol. 37, Núm. 2, pp. 135-142

  2. Prediction and primary prevention of pre-eclampsia

    Best Practice and Research: Clinical Obstetrics and Gynaecology, Vol. 25, Núm. 4, pp. 419-433

  3. Rare cancers are not so rare: The rare cancer burden in Europe

    European Journal of Cancer, Vol. 47, Núm. 17, pp. 2493-2511

2010

  1. Systematic review and meta-analysis of the test accuracy of ductus venosus Doppler to predict compromise of fetal/neonatal wellbeing in high risk pregnancies with placental insufficiency

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 152, Núm. 1, pp. 3-12

  2. The burden of rare cancers in europe

    Advances in Experimental Medicine and Biology, Vol. 686, pp. 285-303